A traditional Chinese medicine granule for treating diffuse pulmonary fibrosis with lung-qi deficiency syndrome
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- HENAN UNIV OF CHINESE MEDICINE
- Publication Date
- 2020-05-15
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] 1. Technical field
[0002] The invention relates to medicine, in particular to traditional Chinese medicine granules (also known as Baofei Huaxian Fang, the same below) for treating diffuse pulmonary interstitial fibrosis with lung-qi deficiency.
[0003] 2. Background technology
[0004] Diffuse pulmonary interstitial fibrosis is a serious and difficult disease of the respiratory system. It is harmful, has a high mortality rate and disability rate, and the prevalence rate is increasing year by year. It seriously endangers the health and quality of life of patients, and the burden of disease is heavy. Diffuse interstitial lung disease is a group of non-neoplastic and non-infectious diseases that mainly involve the alveolar wall, including the tissues around the alveoli and their adjacent supporting structures. Idiopathic pulmonary fibrosis (IPF) ) is one of the most representative diseases. IPF, as a chronic progressive interstitial lung disease of unknown cause with p...